Ethnic variation in the incidence of ALS: A systematic review
Abstract
Background The findings of recent genetic polymorphism studies in ALS suggest that the influence of genetic risk factors for the disease may vary by ethnicity. It is now widely accepted that the incidence of ALS is uniform across Caucasian populations, but whether racial variation across other ethnicities exists remains unknown. Method Systematic review of the known literature on the incidence, prevalence, and mortality of ALS across all ethnicities. To facilitate comparison, studies were grouped according to the type of data presented and examined for sources of case ascertainment and inclusion criteria. Results The literature search identified 61 publications. Lower standardized incidence rates were observed in Asian than Caucasian populations. Within the United States, several incidence and mortality studies have identified lower ALS frequency among African American and Hispanic populations than among non-Hispanic Caucasians. These observations are supported by the other data sources. Conclusions The incidence of ALS may be lower among African, Asian, and Hispanic ethnicities than among whites. We conclude with proposals for a prospective epidemiologic study concentrating on non-Caucasian populations.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The gender distribution (male-to-female ratio = 1.24:1) and gender-dependent differences in average age at symptom onset (56.8 vs 62.1 years) in the cohort were in line with values from previous ALS populations.
“Furthermore, both the distribution of gender (male‐to‐female ratio = 1.24:1) and gender‐dependent differences in average age at symptom onset (56.8 vs. 62.1 years) were in line with values from previous ALS populations, reporting male‐to‐female ratios ranging between 0.8:1 and 2.7:1 (Alonso et al., 2009; Cronin et al., 2007; Uenal et al., 2014) and a tendency for earlier symptom‐onset in men than”
From Prevalence of potential sports‐associated risk factors in Swiss amyotrophic lateral sclerosis patients (2017) · cites this paper as Cronin et al., 2007
Cites
Gompertz, B. (1825) · Philosophical Transactions of the Royal Society of London · doi:10.1098/rstl.1825.0026 · Cited by 3,816 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603 · see citing works
Self-citationChiò, A., Logroscino, G., Traynor, B. J., Collins, J., Simeone, J. C., Goldstein, L. A., & White, L. A. (2013) · Neuroepidemiology · doi:10.1159/000351153 · Cited by 862 · see citing works
Self-citationAmyotrophic lateral sclerosis: translating genetic discoveries into therapies
Akçimen, F., Lopez, E. R., Landers, J. E., Nath, A., Chiò, A., Chia, R., & Traynor, B. J. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00592-y · Cited by 234 · see citing works
Self-citationWang, M.-D., Little, J., Gomes, J., Cashman, N. R., & Krewski, D. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2016.06.015 · Cited by 233 · see citing works
Binazzi, A., Belli, S., Uccelli, R., Desiato, M. T., Talamanca, I. F., Antonini, G., Corsi, F., Scoppetta, C., Inghilleri, M., Pontieri, F., et al. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802382313 · Cited by 46 · see citing works
Feddermann‐Demont, N., Junge, A., Weber, K. P., Weller, M., Dvořák, J., & Tarnutzer, A. A. (2017) · Brain and Behavior · doi:10.1002/brb3.630 · Cited by 29 · see citing works
Watanabe, Y., & Watanabe, T. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0327-y · Cited by 27 · see citing works
- Authors
- Cronin, S., Hardiman, O., & Traynor, B. J.
- Affiliations
- National Institutes of Health (US)
- Venue
- Neurology
- Published
- 2007-03-27
- Volume
- 68
- Issue
- 13
- Pages
- 1002-1007
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2048606094
- Cited by
- 255
- References
- 1
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 7 · 2023: 15 · 2022: 5 · 2021: 7 · 2020: 10 · 2019: 12 · 2018: 9 · 2017: 19 · 2016: 22 · 2015: 20 · 2014: 15 · 2013: 22 · 2012: 22
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Amyloidosis: Diagnosis, Treatment, Outcomes
- Health Sciences › Medicine › Genetics › Neurogenetic and Muscular Disorders Research
- Keywords
- amyotrophic lateral sclerosis, incidence, ethnic differences, racial differences, African Americans, Hispanic population, Asian populations, genetic polymorphism, case ascertainment, prevalence, mortality
- MeSH terms
- Aged, Amyotrophic Lateral Sclerosis, Black or African American, Ethnicity, Hispanic or Latino, Humans, Middle Aged, United States, Incidence, Prevalence, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review